These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 22995409)

  • 41. Selective enrichment of CD133
    Lv K; Chen Z; Zhang X; Zhang Q; Liu L
    Oncol Lett; 2018 Oct; 16(4):4567-4576. PubMed ID: 30197675
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Heterogeneous phenotype of human glioblastoma: in vitro study.
    Denysenko T; Gennero L; Juenemann C; Morra I; Masperi P; Ceroni V; Pragliola A; Ponzetto A; Melcarne A
    Cell Biochem Funct; 2014 Mar; 32(2):164-76. PubMed ID: 23836332
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Potential identity of multi-potential cancer stem-like subpopulation after radiation of cultured brain glioma.
    Kang MK; Hur BI; Ko MH; Kim CH; Cha SH; Kang SK
    BMC Neurosci; 2008 Jan; 9():15. PubMed ID: 18230189
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Glioblastoma Multiforme Stem Cell Cycle Arrest by Alkylaminophenol Through the Modulation of EGFR and CSC Signaling Pathways.
    Doan P; Musa A; Murugesan A; Sipilä V; Candeias NR; Emmert-Streib F; Ruusuvuori P; Granberg K; Yli-Harja O; Kandhavelu M
    Cells; 2020 Mar; 9(3):. PubMed ID: 32164385
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regulation of glioblastoma stem cells by retinoic acid: role for Notch pathway inhibition.
    Ying M; Wang S; Sang Y; Sun P; Lal B; Goodwin CR; Guerrero-Cazares H; Quinones-Hinojosa A; Laterra J; Xia S
    Oncogene; 2011 Aug; 30(31):3454-67. PubMed ID: 21383690
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Glioblastoma specific antigens, GD2 and CD90, are not involved in cancer stemness.
    Woo SR; Oh YT; An JY; Kang BG; Nam DH; Joo KM
    Anat Cell Biol; 2015 Mar; 48(1):44-53. PubMed ID: 25806121
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular heterogeneity in a patient-derived glioblastoma xenoline is regulated by different cancer stem cell populations.
    Garner JM; Ellison DW; Finkelstein D; Ganguly D; Du Z; Sims M; Yang CH; Interiano RB; Davidoff AM; Pfeffer LM
    PLoS One; 2015; 10(5):e0125838. PubMed ID: 25955030
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Direct in vivo evidence for tumor propagation by glioblastoma cancer stem cells.
    Lathia JD; Gallagher J; Myers JT; Li M; Vasanji A; McLendon RE; Hjelmeland AB; Huang AY; Rich JN
    PLoS One; 2011; 6(9):e24807. PubMed ID: 21961046
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular determinants of the interaction between glioblastoma CD133
    Shevchenko V; Arnotskaya N; Pak O; Sharma A; Sharma HS; Khotimchenko Y; Bryukhovetskiy A; Bryukhovetskiy I
    Int Rev Neurobiol; 2020; 151():155-169. PubMed ID: 32448605
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma.
    Ashizawa T; Miyata H; Iizuka A; Komiyama M; Oshita C; Kume A; Nogami M; Yagoto M; Ito I; Oishi T; Watanabe R; Mitsuya K; Matsuno K; Furuya T; Okawara T; Otsuka M; Ogo N; Asai A; Nakasu Y; Yamaguchi K; Akiyama Y
    Int J Oncol; 2013 Jul; 43(1):219-27. PubMed ID: 23612755
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme.
    Pallini R; Ricci-Vitiani L; Banna GL; Signore M; Lombardi D; Todaro M; Stassi G; Martini M; Maira G; Larocca LM; De Maria R
    Clin Cancer Res; 2008 Dec; 14(24):8205-12. PubMed ID: 19088037
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Selective lentiviral gene delivery to CD133-expressing human glioblastoma stem cells.
    Bayin NS; Modrek AS; Dietrich A; Lebowitz J; Abel T; Song HR; Schober M; Zagzag D; Buchholz CJ; Chao MV; Placantonakis DG
    PLoS One; 2014; 9(12):e116114. PubMed ID: 25541984
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro demonstration of salinomycin as a novel chemotherapeutic agent for the treatment of SOX2‑positive glioblastoma cancer stem cells.
    Magrath JW; Raney WR; Kim Y
    Oncol Rep; 2020 Aug; 44(2):777-785. PubMed ID: 32627023
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Grafted Subventricular Zone Neural Stem Cells Display Robust Engraftment and Similar Differentiation Properties and Form New Neurogenic Niches in the Young and Aged Hippocampus.
    Shetty AK; Hattiangady B
    Stem Cells Transl Med; 2016 Sep; 5(9):1204-15. PubMed ID: 27194744
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CD90 is identified as a candidate marker for cancer stem cells in primary high-grade gliomas using tissue microarrays.
    He J; Liu Y; Zhu T; Zhu J; Dimeco F; Vescovi AL; Heth JA; Muraszko KM; Fan X; Lubman DM
    Mol Cell Proteomics; 2012 Jun; 11(6):M111.010744. PubMed ID: 22203689
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Side population is not necessary or sufficient for a cancer stem cell phenotype in glioblastoma multiforme.
    Broadley KW; Hunn MK; Farrand KJ; Price KM; Grasso C; Miller RJ; Hermans IF; McConnell MJ
    Stem Cells; 2011 Mar; 29(3):452-61. PubMed ID: 21425408
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vivo investigation of CD133 as a putative marker of cancer stem cells in Hep-2 cell line.
    Wei XD; Zhou L; Cheng L; Tian J; Jiang JJ; Maccallum J
    Head Neck; 2009 Jan; 31(1):94-101. PubMed ID: 18853445
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Leptin and Notch Signaling Cooperate in Sustaining Glioblastoma Multiforme Progression.
    Panza S; Russo U; Giordano F; Leggio A; Barone I; Bonofiglio D; Gelsomino L; Malivindi R; Conforti FL; Naimo GD; Giordano C; Catalano S; Andò S
    Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32526957
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glioblastoma Multiforme and Adult Neurogenesis in the Ventricular-Subventricular Zone: A Review.
    Capdevila C; Rodríguez Vázquez L; Martí J
    J Cell Physiol; 2017 Jul; 232(7):1596-1601. PubMed ID: 27458813
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CD133 expression defines a tumor initiating cell population in primary human ovarian cancer.
    Curley MD; Therrien VA; Cummings CL; Sergent PA; Koulouris CR; Friel AM; Roberts DJ; Seiden MV; Scadden DT; Rueda BR; Foster R
    Stem Cells; 2009 Dec; 27(12):2875-83. PubMed ID: 19816957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.